Insider acquisitions
Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.
Transaction timeline & trade size
Choose a reporting owner, transaction period, and security. Open any point for the filing.
Purchases in this page13
Other acquisitions37
Reporting owners66
SalesNot providedCheck original SEC filings
Nov 5, 2024 – Dec 19, 2025 · Transaction dates · Current page sample
Reported quantity · security units
Navan, Inc. · Class A Common Stock · Purchase (code P) · Non-derivative · Currency not specified
Swipe the chart to see the full date range. Exact records are available in the table below.
6 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition
50 dated transactions in this page sample · 66 reporting owners.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type | Quantity | Price | Reference value | Currency |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Navan, Inc.Class A Common Stock | CLF Partners, LP (10% owner) · Andreessen Horowitz LSV Fund III, L.P. (10% owner) · AH Equity Partners LSV III, L.L.C. (10% owner) · Andreessen Horowitz LSV Fund III-B, L.P. (10% owner) · AH Equity Partners 2022 Annual Fund, L.L.C. (10% owner) · AH 2022 Annual Fund, L.P. (10% owner) · AH 2022 ANNUAL FUND-QC, L.P. (10% owner) · AH 2022 ANNUAL FUND-B, L.P. (10% owner) | Purchase | 240,835 | 14.7 | 3,540,274.5 | Currency not specified |
| Dec 18, 2025 | Navan, Inc.Class A Common Stock | CLF Partners, LP (10% owner) · Andreessen Horowitz LSV Fund III, L.P. (10% owner) · AH Equity Partners LSV III, L.L.C. (10% owner) · Andreessen Horowitz LSV Fund III-B, L.P. (10% owner) · AH Equity Partners 2022 Annual Fund, L.L.C. (10% owner) · AH 2022 Annual Fund, L.P. (10% owner) · AH 2022 ANNUAL FUND-QC, L.P. (10% owner) · AH 2022 ANNUAL FUND-B, L.P. (10% owner) | Purchase | 103,960 | 13.61 | 1,414,895.6 | Currency not specified |
| Dec 17, 2025 | Navan, Inc.Class A Common Stock | CLF Partners, LP (10% owner) · Andreessen Horowitz LSV Fund III, L.P. (10% owner) · AH Equity Partners LSV III, L.L.C. (10% owner) · Andreessen Horowitz LSV Fund III-B, L.P. (10% owner) · AH Equity Partners 2022 Annual Fund, L.L.C. (10% owner) · AH 2022 Annual Fund, L.P. (10% owner) · AH 2022 ANNUAL FUND-QC, L.P. (10% owner) · AH 2022 ANNUAL FUND-B, L.P. (10% owner) | Purchase | 347,600 | 12.65 | 4,397,140 | Currency not specified |
| Dec 19, 2025 | Navan, Inc.Class A Common Stock | Andreessen Marc L (10% owner) · Andreessen Horowitz LSV Fund I, L.P. (10% owner) · AH Equity Partners LSV I, L.L.C. (10% owner) · Andreessen Horowitz LSV Fund I-Q, L.P. (10% owner) · Andreessen Horowitz LSV Fund I-B, L.P. (10% owner) · Andreessen Horowitz LSV Fund II, L.P. (10% owner) · AH Equity Partners LSV II, L.L.C. (10% owner) · Andreessen Horowitz LSV Fund II-Q, L.P. (10% owner) · Andreessen Horowitz LSV Fund II-B, L.P. (10% owner) | Purchase | 240,835 | 14.7 | 3,540,274.5 | Currency not specified |
| Dec 18, 2025 | Navan, Inc.Class A Common Stock | Andreessen Marc L (10% owner) · Andreessen Horowitz LSV Fund I, L.P. (10% owner) · AH Equity Partners LSV I, L.L.C. (10% owner) · Andreessen Horowitz LSV Fund I-Q, L.P. (10% owner) · Andreessen Horowitz LSV Fund I-B, L.P. (10% owner) · Andreessen Horowitz LSV Fund II, L.P. (10% owner) · AH Equity Partners LSV II, L.L.C. (10% owner) · Andreessen Horowitz LSV Fund II-Q, L.P. (10% owner) · Andreessen Horowitz LSV Fund II-B, L.P. (10% owner) | Purchase | 103,960 | 13.61 | 1,414,895.6 | Currency not specified |
| Dec 17, 2025 | Navan, Inc.Class A Common Stock | Andreessen Marc L (10% owner) · Andreessen Horowitz LSV Fund I, L.P. (10% owner) · AH Equity Partners LSV I, L.L.C. (10% owner) · Andreessen Horowitz LSV Fund I-Q, L.P. (10% owner) · Andreessen Horowitz LSV Fund I-B, L.P. (10% owner) · Andreessen Horowitz LSV Fund II, L.P. (10% owner) · AH Equity Partners LSV II, L.L.C. (10% owner) · Andreessen Horowitz LSV Fund II-Q, L.P. (10% owner) · Andreessen Horowitz LSV Fund II-B, L.P. (10% owner) | Purchase | 347,600 | 12.65 | 4,397,140 | Currency not specified |
| Dec 18, 2025 | Vor Biopharma Inc.Stock Option (Right to Buy) | RA Capital Healthcare Fund LP (Director · 10% owner) · RA CAPITAL MANAGEMENT, L.P. (Director · 10% owner) · Kolchinsky Peter (Director · 10% owner) · Shah Rajeev M. (Director · 10% owner) | Stock award | 3,000 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | ON SEMICONDUCTOR CORPCommon | MASCARENAS PAUL ANTHONY (Director) | Stock award | 189 | 55.21 | 10,434.69 | Currency not specified |
| Dec 18, 2025 | AUTOZONE INCCommon Stock | Hannasch Brian (Director) | Purchase | 147 | 3,393.09 | 498,784.23 | Currency not specified |
| Dec 17, 2025 | DeFi Development Corp.Stock Option (Right to buy) | Kang Daniel (Chief Strategy Officer) | Stock award | 182,616 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | DeFi Development Corp.Stock Option (Right to buy) | Han Fei (Chief Financial Officer) | Stock award | 226,703 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | DeFi Development Corp.Stock Option (Right to buy) | Onorati Joseph Mario (CEO & Chairman · Director · 10% owner) | Stock award | 214,659 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | DeFi Development Corp.Stock Option (Right to buy) | White Parker (COO & Chief Investment Officer · 10% owner) | Stock award | 136,687 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Atkore Inc.Common Stock | MUSE SCOTT H (Director) | Stock award | 130.7386 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Atkore Inc.Common Stock | Isbell Jeri L (Director) | Stock award | 139.4288 | 0 | 0 | Currency not specified |
| Dec 18, 2025 | VERIZON COMMUNICATIONS INCPhantom Stock (unitized) | SCHULMAN DANIEL H (CEO · Director) | Stock award | 230.047 | 11.54 | 2,654.74238 | Currency not specified |
| Dec 18, 2025 | DeFi Capital Markets, Inc.Common Stock | AULT MILTON C III (Director) | Purchase | 2,069 | 4.905 | 10,148.445 | Currency not specified |
| Dec 17, 2025 | DeFi Capital Markets, Inc.Common Stock | AULT MILTON C III (Director) | Purchase | 1,635 | 4.9194 | 8,043.219 | Currency not specified |
| Dec 18, 2025 | CorMedix Inc.Common Stock | Todisco Joseph (Chief Executive Officer · Director) | Exercise / conversion | 30,000 | 4.43 | 132,900 | Currency not specified |
| Dec 17, 2025 | PhenixFIN CorpCOMMON STOCK, $0.001 par value | McMillan Ellida (CHIEF FINANCIAL OFFICER) | Purchase | 37 | 44 | 1,628 | Currency not specified |
| Oct 21, 2025 | OS Therapies IncStock options (right to buy) | Search Theodore F. (Director) | Stock award | 140,000 | 0 | 0 | Currency not specified |
| Oct 21, 2025 | OS Therapies IncStock options (right to buy) | PETIT ROBERT (See Remarks) | Stock award | 500,000 | 0 | 0 | Currency not specified |
| Oct 21, 2025 | OS Therapies IncStock options (right to buy) | Romness Paul A. (President and CEO · Director) | Stock award | 1,950,000 | 0 | 0 | Currency not specified |
| Oct 21, 2025 | OS Therapies IncStock options (right to buy) | Jarry Olivier Roger (Director) | Stock award | 140,000 | 0 | 0 | Currency not specified |
| Oct 21, 2025 | OS Therapies IncStock options (right to buy) | Galzahr Karim (Director) | Stock award | 140,000 | 0 | 0 | Currency not specified |
| Oct 21, 2025 | OS Therapies IncStock options (right to buy) | Ciccio John (Director) | Stock award | 140,000 | 0 | 0 | Currency not specified |
| Oct 21, 2025 | OS Therapies IncStock options (right to buy) | Acevedo Christopher P. (Chief Financial Officer) | Stock award | 200,000 | 0 | 0 | Currency not specified |
| Oct 21, 2025 | OS Therapies IncStock options (right to buy) | McKean-Dieser Avril Suzette (Director) | Stock award | 140,000 | 0 | 0 | Currency not specified |
| Nov 5, 2024 | Tenon Medical, Inc.Restricted Stock Units | Williamson Kevin (Chief Financial Officer · Director) | Stock award | 6,250 | 0 | 0 | Currency not specified |
| Sep 3, 2025 | Tenon Medical, Inc.Common Stock | Williamson Kevin (Chief Financial Officer · Director) | Exercise / conversion | 2,083 | 0 | 0 | Currency not specified |
| Dec 18, 2025 | Churchill Capital Corp XIClass A Ordinary Shares | Klein Michael Stuart (See Remarks · Director · 10% owner) · M. Klein Associates, Inc. (10% owner) · CHURCHILL SPONSOR XI LLC (10% owner) | Purchase | 500,000 | 10 | 5,000,000 | Currency not specified |
| Dec 17, 2025 | LQR House Inc.Common Stock | Lu Yilin (President · Director) | Purchase | 2,000,000 | 0.9 | 1,800,000 | Currency not specified |
| Sep 30, 2025 | LQR House Inc.Common Stock | Lu Yilin (President · Director) | Exercise / conversion | 179 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Velos Acquisition I Corp.Class A common stock | CANTOR FITZGERALD & CO. (10% owner) · CANTOR FITZGERALD, L. P. (10% owner) · CANTOR FITZGERALD SECURITIES (10% owner) · CF GROUP MANAGEMENT INC (10% owner) · Lutnick Brandon (10% owner) | Purchase | 3,529,081 | 10.8 | 38,114,074.8 | Currency not specified |
| Dec 19, 2025 | InMed Pharmaceuticals Inc.Employee Stock Option (Right to Buy) | Johnson Shane Aaron (Sr VP & General Manager) | Stock award | 8,500 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | InMed Pharmaceuticals Inc.Employee Stock Option (Right to Buy) | Lemerond Nicole (Director) | Stock award | 1,750 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | InMed Pharmaceuticals Inc.Employee Stock Option (Right to Buy) | Klompas Neil A (Director) | Stock award | 1,750 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | InMed Pharmaceuticals Inc.Employee Stock Option (Right to Buy) | Jagpal Netta (Chief Financial Officer) | Stock award | 18,000 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | InMed Pharmaceuticals Inc.Employee Stock Option (Right to Buy) | WOUDENBERG MICHAEL (Chief Operating Officer) | Stock award | 18,000 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | InMed Pharmaceuticals Inc.Employee Stock Option (Right to Buy) | Bathery John Steven (Director) | Stock award | 1,750 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | InMed Pharmaceuticals Inc.Employee Stock Option (Right to Buy) | HSU ERIC C (Sr. VP, Pre-Clinical Res/Dev) | Stock award | 13,000 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | InMed Pharmaceuticals Inc.Employee Stock Option (Right to Buy) | ADAMS ERIC A (President & CEO · Director) | Stock award | 35,000 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | InMed Pharmaceuticals Inc.Employee Stock Option (Right to Buy) | HULL ANDREW (Director) | Stock award | 1,750 | 0 | 0 | Currency not specified |
| Dec 18, 2025 | NVIDIA CORPCommon Stock | HUANG JEN HSUN (President and CEO · Director) | Other acquisition | 9,141,011 | 0 | 0 | Currency not specified |
| Dec 18, 2025 | NVIDIA CORPCommon Stock | HUANG JEN HSUN (President and CEO · Director) | Other acquisition | 498,131 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Arcturus Therapeutics Holdings Inc.Employee Stock Option (right to buy) | Roberts Joseph (Controller) | Stock award | 10,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Arcturus Therapeutics Holdings Inc.Employee Stock Option (right to buy) | Chivukula Pad (Chief Scientific Officer & COO) | Stock award | 54,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Arcturus Therapeutics Holdings Inc.Employee Stock Option (right to buy) | Payne Joseph E (President and CEO · Director) | Stock award | 175,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Arcturus Therapeutics Holdings Inc.Employee Stock Option (right to buy) | Kurata Lance (Chief Legal Officer) | Stock award | 54,000 | 0 | 0 | Currency not specified |
| Dec 18, 2025 | ATI INCCommon Stock, par value $0.10 per share | WETHERBEE ROBERT S (Executive Chairman · Director) | Other acquisition | 6,158 | 110.34 | 679,473.72 | Currency not specified |
Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transaction details
Reporting owners, quantities, prices, and source filings.
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | Navan, Inc.NAVN · company listings | CLF Partners, LP10% owner AH Equity Partners LSV III, L.L.C.10% owner AH 2022 Annual Fund, L.P.10% owner AH 2022 ANNUAL FUND-QC, L.P.10% owner AH 2022 ANNUAL FUND-B, L.P.10% owner Joint filing · amounts unallocated | PurchaseClass A Common StockNon-derivative security · Code P | 240,835 | 14.7 *Value: 3,540,274.5Currency not specified | View ↗ |
| Trade: | Navan, Inc.NAVN · company listings | CLF Partners, LP10% owner AH Equity Partners LSV III, L.L.C.10% owner AH 2022 Annual Fund, L.P.10% owner AH 2022 ANNUAL FUND-QC, L.P.10% owner AH 2022 ANNUAL FUND-B, L.P.10% owner Joint filing · amounts unallocated | PurchaseClass A Common StockNon-derivative security · Code P | 103,960 | 13.61 *Value: 1,414,895.6Currency not specified | View ↗ |
| Trade: | Navan, Inc.NAVN · company listings | CLF Partners, LP10% owner AH Equity Partners LSV III, L.L.C.10% owner AH 2022 Annual Fund, L.P.10% owner AH 2022 ANNUAL FUND-QC, L.P.10% owner AH 2022 ANNUAL FUND-B, L.P.10% owner Joint filing · amounts unallocated | PurchaseClass A Common StockNon-derivative security · Code P | 347,600 | 12.65 *Value: 4,397,140Currency not specified | View ↗ |
| Trade: | Navan, Inc.NAVN · company listings | Andreessen Marc L10% owner Andreessen Horowitz LSV Fund I, L.P.10% owner AH Equity Partners LSV I, L.L.C.10% owner AH Equity Partners LSV II, L.L.C.10% owner Joint filing · amounts unallocated | PurchaseClass A Common StockNon-derivative security · Code P | 240,835 | 14.7 *Value: 3,540,274.5Currency not specified | View ↗ |
| Trade: | Navan, Inc.NAVN · company listings | Andreessen Marc L10% owner Andreessen Horowitz LSV Fund I, L.P.10% owner AH Equity Partners LSV I, L.L.C.10% owner AH Equity Partners LSV II, L.L.C.10% owner Joint filing · amounts unallocated | PurchaseClass A Common StockNon-derivative security · Code P | 103,960 | 13.61 *Value: 1,414,895.6Currency not specified | View ↗ |
| Trade: | Navan, Inc.NAVN · company listings | Andreessen Marc L10% owner Andreessen Horowitz LSV Fund I, L.P.10% owner AH Equity Partners LSV I, L.L.C.10% owner AH Equity Partners LSV II, L.L.C.10% owner Joint filing · amounts unallocated | PurchaseClass A Common StockNon-derivative security · Code P | 347,600 | 12.65 *Value: 4,397,140Currency not specified | View ↗ |
| Trade: | Vor Biopharma Inc.VOR · company listings | RA Capital Healthcare Fund LPDirector · 10% owner RA CAPITAL MANAGEMENT, L.P.Director · 10% owner Kolchinsky PeterDirector · 10% owner Shah Rajeev M.Director · 10% owner Joint filing · amounts unallocated | Stock awardStock Option (Right to Buy)Derivative security · Code A | 3,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | ON SEMICONDUCTOR CORPON · company listings | MASCARENAS PAUL ANTHONYDirector | Stock awardCommonNon-derivative security · Code A | 189 | 55.21Value: 10,434.69Currency not specified | View ↗ |
| Trade: | AUTOZONE INCAZO · company listings | Hannasch BrianDirector | PurchaseCommon StockNon-derivative security · Code P | 147 | 3,393.09Value: 498,784.23Currency not specified | View ↗ |
| Trade: | DeFi Development Corp.CHAD · DFDV · DFDVW · company listings | Kang DanielChief Strategy Officer | Stock awardStock Option (Right to buy)Derivative security · Code A | 182,616 | 0Value: 0Currency not specified | View ↗ |
| Trade: | DeFi Development Corp.CHAD · DFDV · DFDVW · company listings | Han FeiChief Financial Officer | Stock awardStock Option (Right to buy)Derivative security · Code A | 226,703 | 0Value: 0Currency not specified | View ↗ |
| Trade: | DeFi Development Corp.CHAD · DFDV · DFDVW · company listings | Onorati Joseph MarioCEO & Chairman · Director · 10% owner | Stock awardStock Option (Right to buy)Derivative security · Code A | 214,659 | 0Value: 0Currency not specified | View ↗ |
| Trade: | DeFi Development Corp.CHAD · DFDV · DFDVW · company listings | White ParkerCOO & Chief Investment Officer · 10% owner | Stock awardStock Option (Right to buy)Derivative security · Code A | 136,687 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Atkore Inc.No current listing · company listings | MUSE SCOTT HDirector | Stock awardCommon StockNon-derivative security · Code A | 130.7386 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Atkore Inc.No current listing · company listings | Isbell Jeri LDirector | Stock awardCommon StockNon-derivative security · Code A | 139.4288 | 0Value: 0Currency not specified | View ↗ |
| Trade: | VERIZON COMMUNICATIONS INCVZ · company listings | SCHULMAN DANIEL HCEO · Director | Stock awardPhantom Stock (unitized)Derivative security · Code A | 230.047 | 11.54Value: 2,654.74238Currency not specified | View ↗ |
| Trade: | DeFi Capital Markets, Inc.DCM · company listings | AULT MILTON C IIIDirector | PurchaseCommon StockNon-derivative security · Code P | 2,069 | 4.905Value: 10,148.445Currency not specified | View ↗ |
| Trade: | DeFi Capital Markets, Inc.DCM · company listings | AULT MILTON C IIIDirector | PurchaseCommon StockNon-derivative security · Code P | 1,635 | 4.9194 *Value: 8,043.219Currency not specified | View ↗ |
| Trade: | CorMedix Inc.CRMD · company listings | Todisco JosephChief Executive Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 30,000 | 4.43Value: 132,900Currency not specified | View ↗ |
| Trade: | PhenixFIN CorpPFX · PFXNZ · company listings | McMillan EllidaCHIEF FINANCIAL OFFICER | PurchaseCOMMON STOCK, $0.001 par valueNon-derivative security · Code P | 37 | 44Value: 1,628Currency not specified | View ↗ |
| Trade: | OS Therapies IncOSTX · company listings | Search Theodore F.Director | Stock awardStock options (right to buy)Derivative security · Code A | 140,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | OS Therapies IncOSTX · company listings | PETIT ROBERTSee Remarks | Stock awardStock options (right to buy)Derivative security · Code A | 500,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | OS Therapies IncOSTX · company listings | Romness Paul A.President and CEO · Director | Stock awardStock options (right to buy)Derivative security · Code A | 1,950,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | OS Therapies IncOSTX · company listings | Jarry Olivier RogerDirector | Stock awardStock options (right to buy)Derivative security · Code A | 140,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | OS Therapies IncOSTX · company listings | Galzahr KarimDirector | Stock awardStock options (right to buy)Derivative security · Code A | 140,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | OS Therapies IncOSTX · company listings | Ciccio JohnDirector | Stock awardStock options (right to buy)Derivative security · Code A | 140,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | OS Therapies IncOSTX · company listings | Acevedo Christopher P.Chief Financial Officer | Stock awardStock options (right to buy)Derivative security · Code A | 200,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | OS Therapies IncOSTX · company listings | McKean-Dieser Avril SuzetteDirector | Stock awardStock options (right to buy)Derivative security · Code A | 140,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Tenon Medical, Inc.TNON · TNONW · company listings | Williamson KevinChief Financial Officer · Director | Stock awardRestricted Stock UnitsDerivative security · Code A | 6,250 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Tenon Medical, Inc.TNON · TNONW · company listings | Williamson KevinChief Financial Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 2,083 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Churchill Capital Corp XICCXI · CCXIU · CCXIW · company listings | Klein Michael StuartSee Remarks · Director · 10% owner M. Klein Associates, Inc.10% owner CHURCHILL SPONSOR XI LLC10% owner Joint filing · amounts unallocated | PurchaseClass A Ordinary SharesNon-derivative security · Code P | 500,000 | 10Value: 5,000,000Currency not specified | View ↗ |
| Trade: | LQR House Inc.YHC · company listings | Lu YilinPresident · Director | PurchaseCommon StockNon-derivative security · Code P | 2,000,000 | 0.9Value: 1,800,000Currency not specified | View ↗ |
| Trade: | LQR House Inc.YHC · company listings | Lu YilinPresident · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 179 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Velos Acquisition I Corp.VLOS · VLOSU · VLOSW · company listings | CANTOR FITZGERALD & CO.10% owner CANTOR FITZGERALD, L. P.10% owner CANTOR FITZGERALD SECURITIES10% owner CF GROUP MANAGEMENT INC10% owner Lutnick Brandon10% owner Joint filing · amounts unallocated | PurchaseClass A common stockNon-derivative security · Code P | 3,529,081 | 10.8Value: 38,114,074.8Currency not specified | View ↗ |
| Trade: | InMed Pharmaceuticals Inc.INM · company listings | Johnson Shane AaronSr VP & General Manager | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 8,500 | 0Value: 0Currency not specified | View ↗ |
| Trade: | InMed Pharmaceuticals Inc.INM · company listings | Lemerond NicoleDirector | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 1,750 | 0Value: 0Currency not specified | View ↗ |
| Trade: | InMed Pharmaceuticals Inc.INM · company listings | Klompas Neil ADirector | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 1,750 | 0Value: 0Currency not specified | View ↗ |
| Trade: | InMed Pharmaceuticals Inc.INM · company listings | Jagpal NettaChief Financial Officer | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 18,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | InMed Pharmaceuticals Inc.INM · company listings | WOUDENBERG MICHAELChief Operating Officer | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 18,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | InMed Pharmaceuticals Inc.INM · company listings | Bathery John StevenDirector | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 1,750 | 0Value: 0Currency not specified | View ↗ |
| Trade: | InMed Pharmaceuticals Inc.INM · company listings | HSU ERIC CSr. VP, Pre-Clinical Res/Dev | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 13,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | InMed Pharmaceuticals Inc.INM · company listings | ADAMS ERIC APresident & CEO · Director | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 35,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | InMed Pharmaceuticals Inc.INM · company listings | HULL ANDREWDirector | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 1,750 | 0Value: 0Currency not specified | View ↗ |
| Trade: | NVIDIA CORPNVDA · company listings | HUANG JEN HSUNPresident and CEO · Director | Other acquisitionCommon StockNon-derivative security · Code J | 9,141,011 | 0Value: 0Currency not specified | View ↗ |
| Trade: | NVIDIA CORPNVDA · company listings | HUANG JEN HSUNPresident and CEO · Director | Other acquisitionCommon StockNon-derivative security · Code J | 498,131 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Arcturus Therapeutics Holdings Inc.ARCT · company listings | Roberts JosephController | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 10,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Arcturus Therapeutics Holdings Inc.ARCT · company listings | Chivukula PadChief Scientific Officer & COO | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 54,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Arcturus Therapeutics Holdings Inc.ARCT · company listings | Payne Joseph EPresident and CEO · Director | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 175,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Arcturus Therapeutics Holdings Inc.ARCT · company listings | Kurata LanceChief Legal Officer | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 54,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | ATI INCATI · company listings | WETHERBEE ROBERT SExecutive Chairman · Director | Other acquisitionCommon Stock, par value $0.10 per shareNon-derivative security · Code S | 6,158 | 110.34 *Value: 679,473.72Currency not specified | View ↗ |
50 transactions on this page. Filing date, newest first.
Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →